Li Qiang, Wang Ping, Ye Keqiang, Cai Hua
Divisions of Molecular Medicine and Cardiology, Departments of Anesthesiology and Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; and.
Department of Pathology, Emory University, Atlanta, GA 30322.
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):899-904. doi: 10.1073/pnas.1420695112. Epub 2015 Jan 5.
Deleted in colorectal cancer (DCC), a large transmembrane receptor of netrin-1, is critical for mediating netrin-1's cardioprotective function. In the present study we investigated novel mechanisms underlying netrin-1-induced, rapid, and feed-forward up-regulation of DCC, which is believed to sustain nitric oxide (NO) production to potentiate cardioprotection. Intriguingly, NO markedly reduced expression of the E3 ubiquitin ligase seven in absentia homolog (SIAH) that is specific for regulation of protesome-dependent DCC degradation, resulting in accumulation of DCC. The two SIAH isoforms compensate for each other when one is repressed; inhibition of both SIAH1 and SIAH2 using combined siRNAs significantly reduced infarct size while improving cardiac function after ischemia/reperfusion injury of the heart. This effect was absent in DCC-deficient mice. Moreover, in vivo RNAi inhibition of SIAH1/2 further augmented netrin-1's cardioprotective function. In summary, these data identify a novel therapeutic target of SIAH in facilitating NO/netrin-1-dependent cardioprotection, using the DCC receptor. Combination of netrin-1 and SIAH RNAi may prove to be a substantially effective therapy for myocardial infarction.
结直肠癌缺失基因(DCC)是一种netrin-1的大型跨膜受体,对介导netrin-1的心脏保护功能至关重要。在本研究中,我们探究了netrin-1诱导的、快速且前馈性上调DCC的新机制,据信这种上调能维持一氧化氮(NO)生成以增强心脏保护作用。有趣的是,NO显著降低了E3泛素连接酶七缺失同源物(SIAH)的表达,该酶特异性调控蛋白酶体依赖性DCC降解,从而导致DCC积累。当一种SIAH亚型受到抑制时,两种亚型可相互补偿;使用组合小干扰RNA(siRNA)抑制SIAH1和SIAH2可显著减小梗死面积,同时改善心脏缺血/再灌注损伤后的心脏功能。在DCC缺陷小鼠中未观察到这种效应。此外,体内RNA干扰抑制SIAH1/2可进一步增强netrin-1的心脏保护功能。总之,这些数据确定了SIAH在促进NO/netrin-1依赖性心脏保护中的一个新治疗靶点,利用DCC受体。netrin-1与SIAH RNA干扰联合应用可能被证明是一种对心肌梗死非常有效的治疗方法。